Home Visit
Upload
QIAstat Dx - Respiratory SARS-CoV-2 Panel
Overview
QIAstat Dx - Respiratory SARS-CoV-2 Panel Overview
The QIAstat Dx respiratory SARS CoV 2 panel is a multiplexed nucleic acid real-time PCR test designed for the qualitative detection and differentiation of nucleic acid from multiple respiratory viral and bacterial organisms, including SARS-CoV-2. This test is used to identify the presence of various pathogens that cause respiratory symptoms in individuals suspected of COVID-19 or other respiratory infections.
The QIAstat Dx respiratory panel can detect and differentiate nucleic acid from 22 different bacteria and viruses, such as SARS-CoV-2, Adenovirus, Coronaviruses (229E, HKU1, NL63, OC43), Human Metapneumovirus, Influenza A and B, Parainfluenza viruses, Rhinovirus/Enterovirus, Respiratory Syncytial Virus, and several bacterial pathogens like Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.
The QIAstat Dx respiratory SARS CoV 2 panel is a crucial tool in the accurate diagnosis and management of respiratory infections, particularly during the ongoing screenings for respiratory infections like human metapneumovirus (HMPV).
Reasons for Undergoing the QIAstat Dx - Respiratory SARS-CoV-2 Panel
There are several key reasons why an individual may undergo the QIAstat Dx respiratory SARS CoV 2 panel:
- Differentiation of Respiratory Pathogens: The panel identifies and differentiates between various respiratory viruses and bacteria, helping in the accurate diagnosis and treatment of respiratory infections like human metapneumovirus (HMPV).
- Diagnosis of COVID-19: The test is used to detect and confirm the presence of SARS-CoV-2 in individuals showing symptoms of COVID-19, enabling prompt diagnosis and appropriate management.
- Rapid Testing: The QIAstat Dx respiratory SARS CoV 2 panel provides quick results, typically within one hour, which is crucial for timely medical intervention and implementation of necessary public health measures.
- Comprehensive Testing: The panel tests for a wide range of respiratory pathogens in a single assay, reducing the need for multiple tests and speeding up the diagnostic process.
List of Parameters Considered During the QIAstat Dx - Respiratory SARS-CoV-2 Panel
The QIAstat Dx respiratory SARS CoV 2 panel identifies nucleic acids of pathogens causing respiratory illnesses. For HMPV (Human Metapneumovirus), it detects a virus linked to respiratory tract infections. Other targets include SARS-CoV-2, adenovirus, influenza A/B, RSV, coronaviruses, rhinovirus/enterovirus, parainfluenza viruses, and bacterial pathogens like Bordetella pertussis and Mycoplasma pneumoniae.
QIAstat Dx - Respiratory SARS-CoV-2 Panel Preparation
The preparation steps for the QIAstat Dx respiratory SARS CoV 2 panel include:
- Sample Collection: A nasopharyngeal swab (NPS) is collected from the individual suspected of having HMPV, COVID-19 or other respiratory infections.
- Automated Processing: The sample is then loaded into the QIAstat-Dx Analyzer 1.0, which performs all the necessary steps automatically, including homogenisation, cell lysis, nucleic acid purification, and PCR amplification.
QIAstat Dx - Respiratory SARS-CoV-2 Panel Results & Interpretation
The results of the QIAstat Dx respiratory SARS CoV 2 panel indicate the presence or absence of the targeted pathogens. Here's how the results should be interpreted:
- Positive Result: Indicates the presence of the specific pathogen(s) detected by the test. For example, a positive result for SARS-CoV-2 confirms COVID-19 infection.
- Negative Result: Indicates that the pathogen(s) were not detected in the sample. However, a negative result does not rule out infection, especially if the sample was collected too early or too late in the course of the disease.
- Interpretation: The test results should be interpreted in conjunction with clinical symptoms, medical history, and other diagnostic findings. The test report will specify which pathogens were detected, and healthcare providers will use this information to guide treatment and management.
Home Collection for QIAstat Dx - Respiratory SARS-CoV-2 Panel
Metropolis Healthcare offers a convenient home sample collection option for the QIAstat Dx respiratory SARS CoV 2 panel, ensuring comfort and safety for patients. A trained phlebotomist will visit your home to collect the necessary samples, maintaining a high standards of sample handling and testing accuracy. This service ensures that you receive timely and reliable results without compromising on the quality of the diagnostic process.
With Metropolis Healthcare's home collection service, you can access quality diagnostic solutions from the comfort of your home, highlighting company's dedication to provide accessible and convenient healthcare for all.
QIAstat Dx - Respiratory SARS-CoV-2 Panel Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the QIAstat Dx - Respiratory SARS-CoV-2 Panel with a clear pricing structure.
The QIAstat Dx - Respiratory SARS-CoV-2 Panel Price in Thrissur is ₹ 15,000 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
The QIAstat Dx respiratory SARS CoV 2 panel is a multiplexed nucleic acid real-time PCR test designed for the qualitative detection and differentiation of nucleic acid from multiple respiratory viral and bacterial organisms, including SARS-CoV-2, in individuals suspected of COVID-19 or other respiratory infections like HMPV.
The QIAstat Dx respiratory panel measures the presence of nucleic acid from various respiratory pathogens, including SARS-CoV-2, other coronaviruses, adenovirus, human metapneumovirus, influenza A and B, parainfluenza viruses, rhinovirus/enterovirus, respiratory syncytial virus, and several bacterial pathogens.
The QIAstat Dx respiratory SARS CoV 2 panel is performed to diagnose HMPV, COVID-19 and other respiratory infections, differentiate between various pathogens, and provide rapid results for timely medical intervention and public health measures.
The QIAstat Dx Respiratory SARS-CoV-2 Panel is recommended for individuals showing symptoms or with a medical history and potential exposure suggesting HMPV, COVID-19, or other respiratory infections. Healthcare providers will assess whether the test is needed.
If the results of the QIAstat Dx respiratory SARS CoV 2 panel are abnormal, meaning one or more pathogens are detected, your healthcare provider will interpret the findings in conjunction with your symptoms and medical history to guide appropriate treatment and management.
During the QIAstat Dx respiratory SARS CoV 2 panel, a nasopharyngeal swab sample will be collected from you by a healthcare professional. The sample is then loaded into the QIAstat-Dx Analyzer 1.0, which automatically processes the sample and provides results.
No specific preparations are required before the QIAstat Dx respiratory SARS CoV 2 panel. However, you should inform your healthcare provider about any medications you are taking and any pre-existing medical conditions you may have.
Your healthcare provider might recommend additional tests, like blood work or imaging studies, alongside QIAstat Dx Respiratory SARS-CoV-2 Panel to further assess your condition and rule out other possible causes of your symptoms.
The QIAstat Dx respiratory SARS CoV 2 panel is also known as the QIAstat Dx respiratory panel or the QIAstat-Dx SARS-CoV-2 test.
Home sample collection is available for the QIAstat Dx respiratory SARS CoV 2 panel at various diagnostic centres, like Metropolis Healthcare. The test requires a nasopharyngeal swab sample to be collected by a trained healthcare professional and processed using the QIAstat-Dx Analyzer 1.0.
The QIAstat Dx Respiratory SARS-CoV-2 Panel offers qualitative results, identifying whether targeted pathogens are present or absent. A negative result across all tested pathogens is deemed normal, while a positive result for any pathogen confirms an infection.
The QIAstat Dx Respiratory SARS-CoV-2 Panel enables rapid, simultaneous detection and differentiation of various respiratory viral and bacterial pathogens, including SARS-CoV-2, in individuals with suspected cases of HMPV, COVID-19, or other respiratory infections.
The frequency of testing for the QIAstat Dx respiratory SARS CoV 2 panel depends on your individual circumstances, such as your symptoms, potential exposure to respiratory pathogens, and your healthcare provider's recommendations. It is not a routine test.
The QIAstat Dx respiratory SARS CoV 2 panel should be done when recommended by your healthcare provider based on your symptoms and potential exposure to respiratory pathogens. There is no specific time of day required for the test.
No, fasting is not required for the QIAstat Dx respiratory SARS CoV 2 panel, as it is a respiratory sample test and does not involve blood collection.
There are no specific precautions to be taken before getting tested for the QIAstat Dx respiratory SARS CoV 2 panel. However, you should inform your healthcare provider of any medications you are taking and any pre-existing medical conditions you may have.
The QIAstat Dx respiratory SARS CoV 2 panel includes the detection and differentiation of nucleic acid from SARS-CoV-2, adenovirus, coronaviruses (229E, HKU1, NL63, OC43), human metapneumovirus, influenza A and B, parainfluenza viruses, rhinovirus/enterovirus, respiratory syncytial virus, and several bacterial pathogens.
The QIAstat Dx respiratory SARS CoV 2 panel typically provides results within one hour, making it a rapid testing method for the detection of respiratory pathogens, including SARS-CoV-2.
The QIAstat Dx Respiratory SARS-CoV-2 Panel provides results after 24 hours. However, report availability may vary based on the provider, facility, and the timing of sample collection and processing.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp
